Studying blood and tissue samples in small cell lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study looks at blood and tissue samples from people with small cell lung cancer to understand why some treatments work better than others. By participating, you will help doctors learn more about this disease and potentially find better ways to treat it in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with small cell lung cancer or another neuroendocrine cancer.
- Your cancer came back after initial treatment (relapsed).
- You are starting or planning to start a drug called a DLL3 bispecific T cell engager.
- You can give blood and are willing to have a tissue biopsy for research.
- You are 18 years old or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with small cell lung cancer who receive radiation therapy combined with other treatments. Researchers will track how well the treatment works and how patients respond over time to help improve future care.
This trial tests a new study drug (PF08634404) combined with standard chemotherapy for people whose non-small cell lung cancer has changed into a more aggressive form called small cell lung cancer. It hopes to improve outcomes by targeting the cancer in two ways.
This trial collects blood and tumor samples from people newly diagnosed with small cell lung cancer to study how genetic markers can predict treatment success and monitor disease over time.
This study collects tissue (and follows patients over time) to better understand the natural course of several types of chest cancers. It may help researchers learn which tests and treatments work best in different cancer types.
This observational study collects information and lab samples from people with extensive-stage small cell lung cancer. It may help researchers understand how patients respond and improve future care, but it usually does not add new treatment for you.
This study uses a lab test called “proteomics” to learn more about newly diagnosed small cell lung cancer (SCLC). It may help researchers understand the disease better and improve future treatment decisions, while participants also receive standard chemotherapy.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.